Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Neovasc Inc. (NVCN : NSDQ)

• Company Description    Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM) for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products, including transcatheter heart valves. Neovasc Inc. is headquartered in Richmond, Canada. Number of Employees: 54

• Price / Volume Information    Yesterday's Closing Price: $5.53 Daily Weekly Monthly 20 Day Moving Average: 27,029 shares Shares Outstanding: 2.71 (millions) Market Capitalization: $14.97 (millions) Beta: 2.48 52 Week High: $28.25 52 Week Low: $4.64 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -41.79% -34.44% 12 Week -48.68% -43.58% Year To Date -52.80% -38.15%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Suite 5138 - 13562 Maycrest Way - RICHMOND,A1 V6V 2J7 CAN ph: 604-248-4138 fax: 604-270-4384 investors@neovasc.com http://www.neovasc.com

• General Corporate Information    Officers Fred Colen - President and Chief Executive Officer Steven Rubin - Chairman and Director Chris Clark - Chief Financial Officer and Secretary Bill Little - Chief Operating Officer Alexei Marko - Director Peer Information Neovasc Inc. (ABMD) Neovasc Inc. (DMDS) Neovasc Inc. (CPWY.) Neovasc Inc. (EQUR) Neovasc Inc. (ECIA) Neovasc Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 64065J403 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/09/22 Share - Related Items Shares Outstanding: 2.71 Most Recent Split Date: 4.00 (0.04:1) Beta: 2.48 Market Capitalization: $14.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.25 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-5.00 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/09/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.34 Price/Cash Flow: - Price / Sales: 5.53 EPS Growth vs. Year Ago Period: -201.00% vs. Previous Quarter: -33.78% Sales Growth vs. Year Ago Period: 35.18% vs. Previous Quarter: -19.50% ROE 03/31/22 - -50.69 12/31/21 - -35.09 09/30/21 - -40.59 ROA 03/31/22 - -39.37 12/31/21 - -27.79 09/30/21 - -30.28 Current Ratio 03/31/22 - 12.88 12/31/21 - 11.08 09/30/21 - 11.16 Quick Ratio 03/31/22 - 12.50 12/31/21 - 10.79 09/30/21 - 10.86 Operating Margin 03/31/22 - -1,016.37 12/31/21 - -844.44 09/30/21 - -859.17 Net Margin 03/31/22 - -1,192.20 12/31/21 - -952.85 09/30/21 - -979.15 Pre-Tax Margin 03/31/22 - -1,211.86 12/31/21 - -973.77 09/30/21 - -1,029.76 Book Value 03/31/22 - 16.17 12/31/21 - 19.31 09/30/21 - 21.31 Inventory Turnover 03/31/22 - 0.42 12/31/21 - 0.41 09/30/21 - 0.37 Debt-to-Equity 03/31/22 - 0.27 12/31/21 - 0.16 09/30/21 - 0.14 Debt-to-Capital 03/31/22 - 21.56 12/31/21 - 13.77 09/30/21 - 12.34

Powered by Zacks Investment Research ©